Distribution of Azithromycin in Plasma and Tonsil Tissue after Repeated Oral Administration of 10 or 20 Milligrams per Kilogram in Pediatric Patients
- 1 May 2002
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (5) , 1594-1596
- https://doi.org/10.1128/aac.46.5.1594-1596.2002
Abstract
Azithromycin concentrations in the tonsils of 56 pediatric patients, treated with 10 or 20 mg of the drug per kg of body weight for 3 days, were compared. Azithromycin levels in plasma and tonsil samples were determined up to 8.5 days after the last dose. The 20-mg/kg regimen resulted in an improved tonsillar distribution of azithromycin, suggesting the achievement of enhanced therapeutic concentrations at infective sites of the upper respiratory tract.Keywords
This publication has 18 references indexed in Scilit:
- Azithromycin versus cefaclor in the treatment of pediatric patients with acute group a beta-hemolytic streptococcal tonsillopharyngitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- AzithromycinDrugs, 1998
- Periodontal Tissue Disposition of AzithromycinThe Journal of Periodontology, 1997
- Concentrations of azithromycin in tonsillar and/or adenoid tissue from paediatric patientsJournal of Antimicrobial Chemotherapy, 1996
- Susceptibility of Helicobacter pylori to simethicone and other non-antibiotic drugsJournal of Antimicrobial Chemotherapy, 1996
- Selection of dose regimens of azithromycinJournal of Antimicrobial Chemotherapy, 1993
- The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactamJournal of Antimicrobial Chemotherapy, 1993
- Concentrations of azithromycin in human tonsillar tissueEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infectionAntimicrobial Agents and Chemotherapy, 1989
- Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organismsAntimicrobial Agents and Chemotherapy, 1987